StonvexLoading…
StonvexStonvexStonvexCore line items from CDRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $155.43M | $610.31M | $443.08M | $287.21M |
Operating Income | $7.49M | $67.35M | $46.91M | $28.24M |
Net Income | $1.98M | $44.14M | $32.40M | $12.21M |
EPS (Diluted) | $0.05 | $1.02 | $0.79 | $0.52 |
Total Assets | $879.74M | $770.03M | $792.05M | $794.44M |
Total Liabilities | $543.62M | $452.23M | $451.68M | $461.98M |
Cash & Equivalents | $41.27M | $122.90M | $150.88M | $137.47M |
Free Cash Flow OCF − CapEx | $19.84M | $56.85M | $38.87M | $17.25M |
Shares Outstanding | 42.80M | 42.16M | 40.68M | 40.66M |